Analysts at Leerink Partnrs raised their FY2026 EPS estimates for shares of Travere Therapeutics in a research note issued to investors on Tuesday, February 11th. Leerink Partnrs analyst J. Schwartz ...
Neurogene (NASDAQ:NGNE – Get Free Report) is projected to release its earnings data before the market opens on Monday, February 17th. Analysts expect Neurogene to post earnings of ($1.10) per share ...